Cover Image
Market Research Report

Asia Pacific Stroke Management Market (2018 - 2024)

Published by KBV Research Product code 763782
Published Content info 98 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia Pacific Stroke Management Market (2018 - 2024)
Published: December 20, 2018 Content info: 98 Pages
Description

The Asia Pacific Stroke Management Market would witness market growth of 8.2% CAGR during the forecast period (2018 - 2024). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs would limit the market growth. Asia-Pacific is the region with tremendous market potential, due to rising prevalence of strokes, which is due to growing incidence of chronic diseases and use of tobacco.

Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.

Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Stroke Management Market, by Type
    • 1.4.2 Asia Pacific Stroke Management Market, by Application
    • 1.4.3 Asia Pacific Stroke Management Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Players Outlook for the Market
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Asia Pacific Stroke Management Market by Type

    • 3.1.1 Asia Pacific Diagnostics Stroke Management Market by Country
      • 3.1.1.1 Asia Pacific Stroke Management Market by Diagnostics Type
        • 3.1.1.1.1 Asia Pacific Stroke Management Computed Tomography Scan (CT Scan) Market by Country
        • 3.1.1.1.2 Asia Pacific Stroke Management Magnetic Resonance Imaging (MRI) Market by Country
        • 3.1.1.1.3 Asia Pacific Stroke Management Echocardiography Market by Country
        • 3.1.1.1.4 Asia Pacific Stroke Management Carotid Ultrasound Market by Country
        • 3.1.1.1.5 Asia Pacific Stroke Management Cerebral Angiography Market by Country
        • 3.1.1.1.6 Asia Pacific Stroke Management Electrocardiography Market by Country
        • 3.1.1.1.7 Asia Pacific Other Diagnostics Type Stroke Management Market by Country
    • 3.1.2 Asia Pacific Therapeutics Stroke Management Market by Country
      • 3.1.2.1 Asia Pacific Stroke Management Market by Therapeutics Type
        • 3.1.2.1.1 Asia Pacific Tissue Plasminogen Activator Stroke Management Market by Country
        • 3.1.2.1.2 Asia Pacific Anticoagulant Stroke Management Market by Country
        • 3.1.2.1.3 Asia Pacific Antiplatelet Stroke Management Market by Country
        • 3.1.2.1.4 Asia Pacific Other Therapeutics Type Stroke Management Market by Country

Chapter 4. Asia Pacific Stroke Management Market by Application

    • 4.1.1 Asia Pacific Ischemic Stroke Management Market by Country
    • 4.1.2 Asia Pacific Haemorrhagic Stroke Management Market by Country

Chapter 5. Asia Pacific Stroke Management Market by Country

  • 5.1 China Stroke Management Market
    • 5.1.1 China Stroke Management Market by Type
      • 5.1.1.1 China Stroke Management Market by Diagnostics Type
      • 5.1.1.2 China Stroke Management Market by Therapeutics Type
    • 5.1.2 China Stroke Management Market by Application
  • 5.2 Japan Stroke Management Market
    • 5.2.1 Japan Stroke Management Market by Type
      • 5.2.1.1 Japan Stroke Management Market by Diagnostics Type
      • 5.2.1.2 Japan Stroke Management Market by Therapeutics Type
    • 5.2.2 Japan Stroke Management Market by Application
  • 5.3 India Stroke Management Market
    • 5.3.1 India Stroke Management Market by Type
      • 5.3.1.1 India Stroke Management Market by Diagnostics Type
      • 5.3.1.2 India Stroke Management Market by Therapeutics Type
    • 5.3.2 India Stroke Management Market by Application
  • 5.4 South Korea Stroke Management Market
    • 5.4.1 South Korea Stroke Management Market by Type
      • 5.4.1.1 South Korea Stroke Management Market by Diagnostics Type
      • 5.4.1.2 South Korea Stroke Management Market by Therapeutics Type
    • 5.4.2 South Korea Stroke Management Market by Application
  • 5.5 Singapore Stroke Management Market
    • 5.5.1 Singapore Stroke Management Market by Type
      • 5.5.1.1 Singapore Stroke Management Market by Diagnostics Type
      • 5.5.1.2 Singapore Stroke Management Market by Therapeutics Type
    • 5.5.2 Singapore Stroke Management Market by Application
  • 5.6 Malaysia Stroke Management Market
    • 5.6.1 Malaysia Stroke Management Market by Type
      • 5.6.1.1 Malaysia Stroke Management Market by Diagnostics Type
      • 5.6.1.2 Malaysia Stroke Management Market by Therapeutics Type
    • 5.6.2 Malaysia Stroke Management Market by Application
  • 5.7 Rest of Asia Pacific Stroke Management Market
    • 5.7.1 Rest of Asia Pacific Stroke Management Market by Type
      • 5.7.1.1 Rest of Asia Pacific Stroke Management Market by Diagnostics Type
      • 5.7.1.2 Rest of Asia Pacific Stroke Management Market by Therapeutics Type
    • 5.7.2 Rest of Asia Pacific Stroke Management Market by Application

Chapter 6. Company Profiles

  • 6.1 B. Braun Melsungen AG.
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental Analysis
    • 6.1.4 Research & Development Expense
  • 6.2 ABBOTT
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Regional & Segmental Analysis
    • 6.2.4 Research & Development Expense
  • 6.3 Cardinal Health
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Segmental Analysis
  • 6.4 Medtronic Plc.
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Segmental and Regional Analysis
    • 6.4.4 Research & Development Expense
  • 6.5 General Electric (GE) (GE Healthcare)
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Segmental and Regional Analysis
    • 6.5.4 Research & Development Expense
  • 6.6 Siemens Healthineers
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Segmental Analysis
    • 6.6.4 Research & Development Expense
  • 6.7 Bristol-Myers Squibb
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Regional Analysis
    • 6.7.4 Research & Development Expense
  • 6.8 Merck & Company Inc.
    • 6.8.1 Company Overview
    • 6.8.2 Financial Analysis
    • 6.8.3 Segmental Analysis
    • 6.8.4 Research & Development Expense
  • 6.9 Glaxosmithkline Plc.
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Segmental Analysis
    • 6.9.4 Research & Development Expense

LIST OF TABLES

  • TABLE 1 ASIA PACIFIC STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 2 ASIA PACIFIC STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 3 ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 4 ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 5 ASIA PACIFIC DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 6 ASIA PACIFIC DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 7 ASIA PACIFIC STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 8 ASIA PACIFIC STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 9 ASIA PACIFIC STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 10 ASIA PACIFIC STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 11 ASIA PACIFIC STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 12 ASIA PACIFIC STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 13 ASIA PACIFIC STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 14 ASIA PACIFIC STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 15 ASIA PACIFIC STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 16 ASIA PACIFIC STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 17 ASIA PACIFIC STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 18 ASIA PACIFIC STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 19 ASIA PACIFIC STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 20 ASIA PACIFIC STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 21 ASIA PACIFIC OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 22 ASIA PACIFIC OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 23 ASIA PACIFIC THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 24 ASIA PACIFIC THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 25 ASIA PACIFIC STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 26 ASIA PACIFIC STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 27 ASIA PACIFIC TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 28 ASIA PACIFIC TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 29 ASIA PACIFIC ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 30 ASIA PACIFIC ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 31 ASIA PACIFIC ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 32 ASIA PACIFIC ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 33 ASIA PACIFIC OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 34 ASIA PACIFIC OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 35 ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 36 ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 37 ASIA PACIFIC ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 38 ASIA PACIFIC ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 39 ASIA PACIFIC HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 40 ASIA PACIFIC HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 41 ASIA PACIFIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
  • TABLE 42 ASIA PACIFIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
  • TABLE 43 CHINA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 44 CHINA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 45 CHINA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 46 CHINA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 47 CHINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 48 CHINA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 49 CHINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 50 CHINA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 51 CHINA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 52 CHINA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 53 JAPAN STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 54 JAPAN STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 55 JAPAN STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 56 JAPAN STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 57 JAPAN STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 58 JAPAN STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 59 JAPAN STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 60 JAPAN STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 61 JAPAN STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 62 JAPAN STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 63 INDIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 64 INDIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 65 INDIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 66 INDIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 67 INDIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 68 INDIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 69 INDIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 70 INDIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 71 INDIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 72 INDIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 73 SOUTH KOREA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 74 SOUTH KOREA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 75 SOUTH KOREA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 76 SOUTH KOREA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 77 SOUTH KOREA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 78 SOUTH KOREA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 79 SOUTH KOREA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 80 SOUTH KOREA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 81 SOUTH KOREA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 82 SOUTH KOREA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 83 SINGAPORE STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 84 SINGAPORE STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 85 SINGAPORE STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 86 SINGAPORE STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 87 SINGAPORE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 88 SINGAPORE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 89 SINGAPORE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 90 SINGAPORE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 91 SINGAPORE STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 92 SINGAPORE STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 93 MALAYSIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 94 MALAYSIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 95 MALAYSIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 96 MALAYSIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 97 MALAYSIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 98 MALAYSIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 99 MALAYSIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 100 MALAYSIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 101 MALAYSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 102 MALAYSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 103 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
  • TABLE 104 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
  • TABLE 105 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
  • TABLE 106 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
  • TABLE 107 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 108 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 109 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
  • TABLE 110 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
  • TABLE 111 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
  • TABLE 112 REST OF ASIA PACIFIC STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
  • TABLE 113 KEY INFORMATION - B. BRAUN MELSUNGEN AG
  • TABLE 114 KEY INFORMATION - ABBOTT
  • TABLE 115 KEY INFORMATION - CARDINAL HEALTH
  • TABLE 116 BUSINESS SEGMENT - CARDINAL HEALTH
  • TABLE 117 KEY INFORMATION - MEDTRONIC PLC
  • TABLE 118 KEY INFORMATION - MEDTRONIC
  • TABLE 119 KEY INFORMATION - GENERAL ELECTRIC (GE)
  • TABLE 120 KEY INFORMATION - SIEMENS HEALTHINEERS
  • TABLE 121 KEY INFORMATION - BRISTOL-MYERS SQUIBB
  • TABLE 122 KEY INFORMATION - MERCK & COMPANY INC.
  • TABLE 123 KEY INFORMATION - GLAXOSMITHKLINE PLC.
Back to Top